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Summary
Introduction
The scope of this thesis is the application of non-invasive vascular measurements in two
conditions characterised by prevalent vascular disease, diabetes mellitus and dyslipidemia.
Functional vascular abnormalities are found very early in both diabetes mellitus and
dyslipidemia, but it may take decades before clinical manifestations become apparent,
and even then, in only part of these patients. Metabolic data, like glycemic or lipidemic
history and status, provide limited predictive power for the risk of clinical vascular disease
in an individual patient. Genetic characteristics may have some additive predictive value
in future, but monitoring of the functional and structural vascular condition may yet be
the most feasible tool to predict the risk for clinical events and form the best guide for
interventions. It may also give direct information on the pathophysiology of vascular
disease.
This thesis shows that a classical non-invasive vascular method, ankle pressure
measurement, is insufficient to monitor the effects of an intervention (chapter 5). Another
non-invasive vascular measurement method, the intima-media thickness (IMT), has been
extensively used for this purpose in lipidJowering studies, and is reviewed in chapter 7
and 8. In chapter 6 the effects on the IMT are compared of initial and long-term lipid-
lowering therapy in dyslipidemia. The IMT method is also used to detect early structural
vascular abnormalities in patients with glycogen storage disease Ia, expected to be
particularly prone to cardiovascular disease (chapter 9). The IMT may serve as a mirror
of the final common pathway of atherosclerosis of large arteries, but provides little insight
in pathophysiologic hanges. To this end, in chapters 2-4, a new bio-impedance method
is used to compare various properties of an upper arm vascular bed, as blood volume,
compliance and distensibiliry in diabetic patients and control subjects. Apart from changes
in arterial compliance and distensibiliry the method also illustrates venous abnormalities
in diabetes. Several results fit the hemodynamic angiopathic hypothesis. One of the
studies also provides preliminary results on the predictive value of some vascular parameters
in developing long-term vascular complications.
Diabetes mellitus
Since the pathogenesis and epidemiology of micro- and macrovascular complications in
rype I (insulin-dependent) and 2 (insulin-independent) diabetes are different, (sub)clinical
vascular changes were compared in both types of diabetes, as described in chapter 2.
Parameters of the whole vascular bed of the upper arm were simultaneously assessed by
our bio-impedance methodín 53 rype I and 28 type 2 diabetic patients, as well as in 33
healthy control subjects. Diabetic complications were divided into micro- and
macrovascular. The systolic blood pressure and pulse pressure were elevated in all diabetic
patients compared with the control subjects. The maximum compliance and distensibiliry
of the large arteries were decreased in rype 2 compared with rype I diabetes and the
control sub.jects. The distensibiliry of the total arterial bed was increased in rype 2 diabetes
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compared with the control subjects. These vascular changes in type 2 diabetes, despite
conventional treatment, fit the hemodynamic angiopathic hypothesis. After a follow-up
period, ranging from 4.5 to 7 years, progression of microvascular disease was found in
30and 25o/oandofmacrovasculardisease in25and43o/oof thepatientswithtype l and
2 diabetes, respectively. For both type 1 and 2 diabetes, different vascular parameters
were of predictive value in developing diabetic com-plications. Apart from generally
accepted risk predictors like conventionally measured blood pressure and pulse pressure,
maximum arterial compliance seemed to be important as such an indicator in type I
diabetes, and blood volume of the large arteries and the cuff pressure at which the veins
start to refill in type 2 diabetes.
In chapter 3, our first cross-sectional observation in type I diabetes is described,
concerning the possible relation between diabetes associated changes in cortisol
metabolism and volume homeostasis, and their relation to metabolic control. The cortisol
to cortisone metabolite ratio reflects the overall direction of cortisol to its inactive
metabolite cortisone interconversion, catalysed by 11B-hydroxysteroid dehydrogenase
(l l PHSD). By measuring various plasma and urinary steroids and metabolites, changes
in I l BHSD activity can be assessed. In 8 normo- and microalbuminuric type I diabetic
patients and 8 healthy control subjects, cortisol metabolism was evaluated and total
blood volume assessed using our bio-impedance measurement. In both diabetic groups,
urinary excretion of steroid metabolites was lower compared with the control group.
Both the cortisol to cortisone metabolite ratio, and a parameter of 5crl5B-reduction of
cortisol, were lower in the diabetic patients. In all combined diabetic subjects, most of
these parameters were inversely correlated with diabetic control. Total blood volume of
the upper arm was positively correlated with the cortisol to cortisone metabolite ratio in
both the diabetic patients and the control subjects, with a leftward shift of the regression
line in all diabetic participants. The cortisol to cortisone metabolite ratio decreased further
after administering of an angiotensin-converting enzyme (ACE) inhibitor in 7
microalbuminuric diabetic patients. These data provide evidence for a disturbed balance
of 1 l BHSD and an impaired reduction of corticoids in type 1 diabetes. Notwithstanding
the existing relation between total blood volume and the cortisol to cortisone metabolite
ratio, the altered I l FHSD activiry cannot primarily be responsible for the sodium and
fluid retention.
In the other cross-sectional observation in type I diabetes, described in chapter 4, blood
volume distribution was evaluated. A supposedly impaired activity of endothelium-derived
nitric oxide in rype I diabetes, will cause an increased vascular tone in arteries. Considering
the lower production of nitric oxide in veins than in arteries, an impaired activity would
have less vasoconstrictive effects in veins. As the total plasma volume in diabetes is
minimally changed, a redistribution of blood volumes from the arterial to the venous
side of the circulation can be postulated. Therefore, in l6 normo- and microalbuminuric
type 1 diabetic patients and 16 matched healthy control subjects, blood volumes, venous
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myogenic response and arterial distensibilities were assessed in the upper arm using our
electrical bio-impedance method. In diabetic patients the venous bïood ,rol1r-.""rrd
venous myogenic response were increased whereas the arterial blood volume did not
thange. Moreover' in diabetic patients the distensibility of the large arreries was decreased,
but an increase in distensibility was found of the total 
"rt.rl"l 
bed. Therefore, rhe
distensibility of the small arteries must have been increased. No differences were found
between the normo- and microalbuminuric diabetic parienrs. These changes are in
agreement with the expected shift of blood volume from the arterial to the váous side
T ty.P. I diabetes, poisibly .related to an impaired activity o. ...forr. of nitric oxide.Furthermore, they support the hemodynamii hypothesis of the p"ihog..r.ri. of diabetic
microangiopathy.
Yl\ltg training is an established conservative trearmenr for patients with intermittent
claudication. The often distally localised obstructive lesions an^d mi..o.,,,ascular disease in
diabetes can-complicate other (reconstructive) therapies, and probably walking training
as yefl In chapter 5, the results of ahalf-year supeivised *ih.,g progr*- ii patientï
with limiting_intermittent claudication and pràrren peripheral-vascular disease are
described.'l7alkingparameters were determined in al 6oih type I and 2) diabetic patients
and 136 control 
-subjects every 2 months, while vascula. p"r"-.,.r, *ere obtained at the
start and end of the program. of the 33 diabedc patients, 25 (76vo) completed the
program' as did 87 of the 136 (640/o) control subjects. A-€ter the training program, th.
symptom-free. walking distance and the maximum walking distance wel sigáificantly
inc.reased.in diabetic patients and in control subjects. ThË relative gain in maximum
walking distance was 8870 greater in the diabetic patients .o-p"..i with the conrrol
subjects. The vascular parameters were comparable for both group, before and after the
training' The greater relative gain ofwalking training in diabetes à.r.,o, be explained by
the measured vasculat parameters, so must b. .aused by other facrors, like microàirculatory
changes. These study results illustrate the inability of the classical 
"nkl. 
pr.rru.., tá
predict or monitor the clinical response.
Dyslipidemia
After the demonsrrated favourable effects of lipid-lowering therapy on the ultra-
sonographically measured IMT by several intervenlion trials, tËe .flè.i, of initial versus
long-term lipid-lowering treatment on vascular wall characteristics were studied and are
described. in chapter 6. Patients with hypercholesterolemia (>6.5 mmol/l) were
retrospectively divided according to lipid-lowering therapy at baseline and treated during
1 year with the 3 hydroxy-3-methylglutaryl-àoenty^, A (HMG-coA) reductasË
inhibitors simva- or pravastatin to reduce total cholesterol below 5 mmol/l. At baseline
no differences were found in biochemical and various vascular paramerers between the
30 previously untreated ('initial') and the 54 abeady convention"lly treated ('long-term )patients,.except for- triglycerides, which were highei in the initial grorp. Aftèr 1 Ë"r, ,t .
relative changes in lipid profile were significantly better in the initlal- io-p"r.d with the
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long-term group. The relative changes in IMT of the mean internal carodd and common
femoral arteries significantly differed berween both groups, with a decrease in the initial-
and an increase in the long-term group. After 1 year, in both groups, most other vascular
wall characteristics were unaltered compared with baseline. fu in both groups lipid profile
was improved and no correlations could be found between the changes in lipid profile
and IMT, other, including initial, effects of HMG-CoA reductase inhibitors than lipid-
lowering alone must be involved in vascular changes.
The IMT of superficial arge arteries is frequently used in intervention trials as 'surrogate
endpoint' of cardiovascular disease. Studies concerning the influence of lipid-lowering,
antihypertensive and some other therapies on the IMT of the carotid artery, are reviewed
in chapter 7, and up-dated in chapter 8. After I year of lipid-lowering treatment, a
reduced progression rate of the IMT was seen and aggressive lipidJowering therapy
proved to be more beneficial than conventional therapy. Little evidence supported a
reduction of IMT progression in high-risk persons by antihypertensive drugs, like ACE
inhibitors, beta-blockers and a calcium-channel blocker. No information was available
about the effects on the IMT of combined lipidJowering and antihypertensive treatment
or homocysteine-lowering therapy. Intensified diabetes treatment did not seem to
influence the IMT. Although some results were derived from substudies or secondary
endpoint analyses, hormone replacement therapy had possibly beneficial effects on the
IMT in contrast to antioxidant supplementation in high-risk individuals. The effects of
non-pharmacological ife sryle modification on IMT appeared to be promising. Since
carotid IMT proved to be an independent cardiovascular risk predictor, it can be used as
risk assessment in the individual patient. The range of treatment-induced changes in
IMT does not support the use of IMT measurements in an individual patient to monitor
treatment effects.
Deficiency of microsomal glucose-6-phosphatase l ads to glycogen storage disease Ia
(GSD Ia). Although more patients with GSD Ia reach adult age, no information is still
available about the occurrence of cardiovascular disease in this condition, with persisting
dyslipidemia and microalbuminuria despite dietary therapy. In chapter 9, our cross-
sectional observation is described, which investigated whether GSD Ia was associated
with premature cardiovascular changes. In 9 adolescent patients with GSD Ia and 9
matched healthy control subjects, lipid profile, non-invasive vascular measurements and
echocardiography were performed. As expected, I ipid profi les were significantly
unfavourable in the patient compared with the control group. Seven patients with GSD
Ia were treated with an ACE inhibitor because of (micro)albuminuria. Blood pressure
was comparable in both groups. The IMT of the carotid and femoral arteiies *as
comparable in both groups, with even significantly thinner values for some segments of
the patients with GSD Ia. The relative myocardial wall thickness was significantly higher
and the early to atrial filling ratio of the left ventricle lower in the patients with GSD Ia
compared with the control subjects, fitting incipient cardiac remodeling and diastolic
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dysfunction, respectively. After controlling for known cardiovascular risk factors in
different multivariate models, GSD Ia remained an independent predictor for a thinner
IMT and increase in relative myocardial thickness. Thus, despite the existence of





Diabetes mellitus, both type I and2, is a condition with a wide range of known vascular
abnormalities at various levels of the vascular tree. The bio-impedance technique allows
us to collect some vascular characteristics, which cannot readily and/or simultaneously
be obtained usins other methods.
The lower maximum compliance and large arteÍy distensibil i ty and higher
distensibility of the total arterial bed in type 2 diabetes fit the hemodynamic
angiopathic hypothesis. Vascular parameters of the upper arm, predicting long-term
micro- and macrovascular complications, are different for rype I (maximum arterial
compliance) and rype 2 diabetes (blood volume of the large arteries and the cuff
pressure at which the veins start to refill).
In type I diabetes, the l1BHSD activiry is altered and the reduction of corticoids
impaired. Activiry of 1 l BHSD, reflected by the cortisol to cortisone metabolite ratio,
is positively correlated with upper arm segmental blood volume, in both rype 1 diabetic
and nondiabetic participants, but cannot be primarily responsible for the sodium
and fluid retention.
In type 1 diabetes, the venous blood volume and venous myogenic response are
increased, whereas the arterial blood volume remains unchanged. Because the
distensibiliry is decreased ofthe large arteries, but increased ofthe total arterial bed
and, therefore, of the smaller arteries, a redistribution of blood volume from the
arterial towards the venous side can be postulated.
Walhing naining
\flalking training is an effective treatment for intermittent claudication, with a greater
relative gain in diabetic patients. Classical vascular characteristics did not predict the
success of walking training, and did not change by the training program in correspon-
dence with the changes in walking distances.
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Dyslipidemia
Dyslipidemia is a harmful condition for the vascular tree, by promoting atherosclerosis.
IMT measurements allow detection of preclinical changes in the wall of large superficial
arteries, like the carodd and femoral artery. Our review and application of this technique
concerned conditions with possible or established atherosclerosis.
. After I year or more of lipid-lowering treatment a reduced progression rate of the
carotid IMT has been seen in several intervention trials.
. Little evidence supports a reduction of the IMT progression rate by antihypertensive
drugs. Still insufficient, but partly promising, evidence is found for the influence of
other therapies on the carotid IMT.
Measurement of the carodd IMT can be useful in the cardiovascular risk assessment
of the individual patient, but not in monitoring treatment efFects.
Initiating lipidJowering treatment with HMG-CoA reductase inhibitors has a more
beneficial effect on the IMT progression than continuing already existing therapy,
partly independent of the lipidJowering effects.
Glycogen storage disease Ia is associated with incipient cardiac remodeling and diastolic
dysfunction but not with atherosclerosis, as detectable by IMT measurements, despite
the existence of longstanding dyslipidemia and microalbuminuria.
